Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

BACKGROUND: Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differentiation antigens. CCS is poorly sensitive to chemotherapy. Multi-kinase inhibitor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Tazzari, Marcella, Palassini, Elena, Vergani, Barbara, Villa, Antonello, Rini, Francesca, Negri, Tiziana, Colombo, Chiara, Crippa, Flavio, Morosi, Carlo, Casali, Paolo G, Pilotti, Silvana, Stacchiotti, Silvia, Rivoltini, Licia, Castelli, Chiara
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342079/
https://ncbi.nlm.nih.gov/pubmed/25880253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1044-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia